156 related articles for article (PubMed ID: 27916471)
1. The efficacy of faropenem for patients with acute cystitis caused by extended spectrum β-lactamase producing Escherichia coli.
Fujino K; Hiyama Y; Uehara T; Ichihara K; Hashimoto J; Fujii S; Shinagawa M; Takahashi S; Masumori N
J Infect Chemother; 2017 May; 23(5):336-338. PubMed ID: 27916471
[TBL] [Abstract][Full Text] [Related]
2. The use of nitrofurantoin for children with acute cystitis caused by extended-spectrum Β-lactamase-producing Escherichia coli.
Kara A; Gurgoze MK
J Pediatr Urol; 2019 Aug; 15(4):378.e1-378.e5. PubMed ID: 31014984
[TBL] [Abstract][Full Text] [Related]
3.
Ishikawa K; Uehara Y; Mori N; Mikami Y; Tokioka S; Kobayashi D; Goke H; Inukai T; Sakurai A; Doi Y; Kawakami S; Kayama S; Sugai M; Nakamura S
Antimicrob Agents Chemother; 2022 Jun; 66(6):e0012522. PubMed ID: 35647649
[TBL] [Abstract][Full Text] [Related]
4. Single-dose amikacin plus 7 days of amoxicillin/clavulanate to treat acute cystitis caused by extended-spectrum beta-lactamase-producing
Ahn ST; Han DE; Lee DH; Kim JW; Park HS; Moon DG; Oh MM
Investig Clin Urol; 2021 May; 62(3):310-316. PubMed ID: 33943052
[TBL] [Abstract][Full Text] [Related]
5. Does urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli show same antibiotic resistance when it recurs?
Ahn ST; Kim SW; Kim JW; Park HS; Moon DG; Oh MM
J Infect Chemother; 2019 Jul; 25(7):498-502. PubMed ID: 30852104
[TBL] [Abstract][Full Text] [Related]
6. Role of piperacillin/tazobactam as a carbapenem-sparing antibiotic for treatment of acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.
Yoon YK; Kim JH; Sohn JW; Yang KS; Kim MJ
Int J Antimicrob Agents; 2017 Apr; 49(4):410-415. PubMed ID: 28263710
[TBL] [Abstract][Full Text] [Related]
7. Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality.
Peña C; Gudiol C; Calatayud L; Tubau F; Domínguez MA; Pujol M; Ariza J; Gudiol F
J Hosp Infect; 2008 Feb; 68(2):116-22. PubMed ID: 18226420
[TBL] [Abstract][Full Text] [Related]
8. Treatment of acute uncomplicated cystitis with faropenem for 3 days versus 7 days: multicentre, randomized, open-label, controlled trial.
Hamasuna R; Tanaka K; Hayami H; Yasuda M; Takahashi S; Kobayashi K; Kiyota H; Yamamoto S; Arakawa S; Matsumoto T;
J Antimicrob Chemother; 2014 Jun; 69(6):1675-80. PubMed ID: 24508899
[TBL] [Abstract][Full Text] [Related]
9. [Ertapenem administered intravenously or subcutaneously for urinary tract infections caused by ESBL producing enterobacteriacea].
Forestier E; Gros S; Peynaud D; Levast M; Boisseau D; Ferry-Blanco C; Labe A; Lecomte C; Rogeaux O
Med Mal Infect; 2012 Sep; 42(9):440-3. PubMed ID: 22925551
[TBL] [Abstract][Full Text] [Related]
10. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics of Bacteremia Caused by Extended-spectrum Beta-lactamase-producing Escherichia coli at a Tertiary Hospital.
Namikawa H; Yamada K; Fujimoto H; Oinuma KI; Tochino Y; Takemoto Y; Kaneko Y; Shuto T; Kakeya H
Intern Med; 2017; 56(14):1807-1815. PubMed ID: 28717075
[TBL] [Abstract][Full Text] [Related]
12. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study of the urinary tract infections due to Escherichia coli harboring extended-spectrum beta lactamase].
Hori J; Yamaguchi S; Osanai H; Kinebuchi T; Usami K; Takahashi N; Ishii Y
Hinyokika Kiyo; 2007 Nov; 53(11):777-82. PubMed ID: 18051801
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.
Park SH; Choi SM; Chang YK; Lee DG; Cho SY; Lee HJ; Choi JH; Yoo JH
J Antimicrob Chemother; 2014 Oct; 69(10):2848-56. PubMed ID: 24928854
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents.
Liu HC; Hung YP; Lin HJ; Liu HC; Lee JC; Wu YH; Li CW; Li MC; Ko WC
J Microbiol Immunol Infect; 2016 Aug; 49(4):584-90. PubMed ID: 26692184
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
Chopra T; Marchaim D; Johnson PC; Chalana IK; Tamam Z; Mohammed M; Alkatib S; Tansek R; Chaudhry K; Zhao JJ; Pogue JM; Kaye KS
Am J Infect Control; 2015 Jul; 43(7):719-23. PubMed ID: 25934068
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes with ertapenem as a first-line treatment option of infections caused by extended-spectrum β-lactamase producing gram-negative bacteria.
Fong JJ; Rosé L; Radigan EA
Ann Pharmacother; 2012 Mar; 46(3):347-52. PubMed ID: 22395250
[TBL] [Abstract][Full Text] [Related]
18. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.
Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH
J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784
[TBL] [Abstract][Full Text] [Related]
19. Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities.
Saltoglu N; Karali R; Yemisen M; Ozaras R; Balkan II; Mete B; Tabak F; Mert A; Hondur N; Ozturk R
Int J Clin Pract; 2015 Jul; 69(7):766-70. PubMed ID: 25683907
[TBL] [Abstract][Full Text] [Related]
20. Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
Cho SY; Choi SM; Park SH; Lee DG; Choi JH; Yoo JH
Korean J Intern Med; 2016 Jan; 31(1):156-61. PubMed ID: 26767869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
